B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note
BioPlus Co Ltd
/
Income Statement
/
Revenue

BioPlus Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioPlus Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Revenue
₩65B
CAGR 3-Years
39%
CAGR 5-Years
43%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Revenue
₩655.7B
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Revenue
₩51.9B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
10%
T
T&L Co Ltd
KOSDAQ:340570
Revenue
₩115.5B
CAGR 3-Years
42%
CAGR 5-Years
34%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Revenue
₩16.6B
CAGR 3-Years
-54%
CAGR 5-Years
11%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Revenue
₩119.1B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
11%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is BioPlus Co Ltd's Revenue?
Revenue
65B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Revenue amounts to 65B KRW.

What is BioPlus Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
43%

Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for BioPlus Co Ltd have been 39% over the past three years , 43% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.